gefitinib has been researched along with ruthenium in 2 studies
| Studies (gefitinib) | Trials (gefitinib) | Recent Studies (post-2010) (gefitinib) | Studies (ruthenium) | Trials (ruthenium) | Recent Studies (post-2010) (ruthenium) |
|---|---|---|---|---|---|
| 5,231 | 566 | 2,919 | 6,854 | 7 | 3,883 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hao, X; Ji, L; Li, X; Lin, Y; Lü, S; Luo, Q; Wang, F; Wang, X; Yang, L; Zheng, W | 1 |
| Du, J; Kang, Y; Lin, Y; Luo, Q; Wang, F; Wang, Y; Wang, Z; Wu, K; Zhang, Y; Zhao, Y; Zheng, W | 1 |
2 other study(ies) available for gefitinib and ruthenium
| Article | Year |
|---|---|
Novel ruthenium complexes ligated with 4-anilinoquinazoline derivatives: synthesis, characterisation and preliminary evaluation of biological activity.
Topics: Aniline Compounds; Antineoplastic Agents; Apoptosis; Cell Proliferation; Cell Survival; Crystallography, X-Ray; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; ErbB Receptors; Gefitinib; Humans; MCF-7 Cells; Models, Molecular; Molecular Structure; Organometallic Compounds; Quinazolines; Ruthenium; Structure-Activity Relationship | 2014 |
Synthesis, Characterization, and in Vitro Antitumor Activity of Ruthenium(II) Polypyridyl Complexes Tethering EGFR-Inhibiting 4-Anilinoquinazolines.
Topics: 2,2'-Dipyridyl; Aniline Compounds; Antineoplastic Agents; Apoptosis; Benzimidazoles; Cell Line, Tumor; Cisplatin; Coordination Complexes; DNA; ErbB Receptors; Fluorescent Dyes; Gefitinib; Humans; Hydrolysis; Ligands; Membrane Proteins; Phenanthrolines; Quinazolines; Ruthenium | 2016 |